About US
Contact us
-
FDA grants Breakthrough Therapy Designation for Shire’s SHP621 and SHP625Biopharmaceutical company Shire has received the US Food and Drug Administration's (FDA) breakthrough therapy designation for its two investigational drug candidates. The investigational drugs are in2016/6/16
-
Charleston Laboratories and Daiichi Sankyo’s NDA for CL-108 receives FDA acceptanceThe collaboration of US-based pharmaceutical company Charleston Laboratories and Japanese pharmaceutical company Daiichi Sankyo has received acceptance from the US Food and Drug Administration (FDA) f2016/6/15
-
US WRAIR and Beth Israel Deaconess to conduct preclinical research on Zika vaccine candidateScientists from US Walter Reed Army Institute of Research (WRAIR) have collaborated with Beth Israel Deaconess Medical Centre in Boston, Massachusetts, to conduct preclinical research on a Zika vaccin2016/6/15
-
FDA takes legal action against 4,402 unlawful drug-selling websitesThe US Food and Drug Administration (FDA) and the international regulatory and law enforcement agencies have taken action against 4,402 websites that illegally sell dangerous and unapproved prescripti2016/6/14
-
PaxVax receives US marketing approval from FDA for cholera vaccineUS-based biotechnology company PaxVax has received marketing approval from the US Food and Drug Administration (FDA) for cholera vaccine, Vaxchora. The single-dose oral, live attenuated cholera vacci2016/6/14
-
Merck signs definitive agreement to buy US firm Afferent PharmaceuticalsUS drug company Merck has signed a definitive agreement to acquire privately held US-based clinical-stage biotechnology company Afferent Pharmaceuticals. Known as Merck Sharp & Dohme (MSD) outsid2016/6/13
-
Report: Crisaborole to benefit from the merger between Pfizer and AnacorThe $5.2bn impending merger between Pfizer and Anacor is expected to accelerate the marketing and commercialisation of Anacor's atopic dermatitis pipeline candidate Crisaborole, according to a report2016/6/13
-
Thailand certified to be free of mother-to-child HIV transmissionThe Ministry of Public Health has officially declared Thailand to be the first country in Asia to be free of the transmission of human immunodeficiency virus (HIV) and syphilis from mothers to their i2016/6/12
-
Cancer Research UK to develop new bubbly drink for effective cancer treatmentScientists from Cancer Research UK are developing a drink that is packed with oxygen microbubbles with an aim to provide more potential treatment for hard-to-treat tumours such as pancreatic cancer.2016/6/12
-
Genisphere and AstraZeneca’s MedImmune ink R&D, licensing dealPennsylvania nanotech company Genisphere and AstraZeneca’s ($AZN) biologics R&D company MedImmune have agreed to formalize a collaboration on research with an option to license nanoparticles using2016/6/8